Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Novavax Inc (NVAX) stock saw a decline, ending the day at $11.92 which represents a decrease of $-0.37 or -3.01% from the prior close of $12.29. The stock opened at $11.75 and touched a low of $11.09 ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $13.61 which represents a slight increase of $1.69 or 14.18% from the prior close of $11.92. The stock opened at $11.87 and touched a ...

Buying $1000 In NVAX: If an investor had bought $1000 of NVAX stock 5 years ago, it would be worth $2,000.00 today based on a ...

Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...

Vaccine maker Novavax (NASDAQ: NVAX) is having a good year. In May, the company announced a lucrative partnership with French biotech giant Sanofi (NASDAQ: SNY), sending its stock price soaring.

Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back. Novavax, Inc. (Nasdaq: NVAX), a global company advancing ...

NVAX’s share price and volume action is mimicking its strong fundamental possibilities. The stock is carving out a bullish monthly bull flag pattern. Shares should accelerate to the upside if ...